Discover more insights into Dopaminergic Neurodegeneration

Keywords frequently search together with Dopaminergic Neurodegeneration

Narrow sentence examples with built-in keyword filters

Dopaminergic Neurodegeneration sentence examples within Induced Dopaminergic Neurodegeneration



Glycation modulates glutamatergic signalling and exacerbates Parkinson’s disease-like phenotypes



Alpha Mangostin Confers Neuroprotection Against Rotenone-induced Parkinson’s Disease via Modulating Autophagy and AMPK Signaling.


Dopaminergic Neurodegeneration sentence examples within Progressive Dopaminergic Neurodegeneration



Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro



Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism


Dopaminergic Neurodegeneration sentence examples within Striatal Dopaminergic Neurodegeneration



Rapid eye movement sleep deprivation enhances vulnerability of striatal dopaminergic neurons to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine neurotoxicity in mice



Leucine‐rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes



Learn more from Dopaminergic Neurodegeneration


Dopaminergic Neurodegeneration sentence examples within dopaminergic neurodegeneration induced



Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism



Dopaminergic Neurodegeneration Induced by Parkinson’s Disease-Linked G2019S LRRK2 is Dependent on Kinase and GTPase Activity



Genetic background influences LRRK2-mediated Rab phosphorylation in the rat brain



Glycation modulates glutamatergic signalling and exacerbates Parkinson’s disease-like phenotypes



Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson’s disease



Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis



Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration.



Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease



Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation



Chronic–Progressive Dopaminergic Deficiency Does Not Induce Midbrain Neurogenesis



Alpha Mangostin Confers Neuroprotection Against Rotenone-induced Parkinson’s Disease via Modulating Autophagy and AMPK Signaling.



Anesthetic Effects on the Progression of Parkinson Disease in the Rat DJ-1 Model



α‐Synuclein evokes NLRP3 inflammasome‐mediated IL‐1β secretion from primary human microglia



Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegeneration



BTBD9 is a novel component of IGF signaling and regulates manganese-induced dopaminergic dysfunction



MiR-132-3p promotes neuroinflammation and dopaminergic neurodegeneration by suppressing glutaredoxin expression.



Nutritive Manganese and Zinc Overdosing in Aging C. Elegans Result in a Metallothionein-Mediated Alteration in Metal Homeostasis.



VPS35 Protects Against TMEM230-Mutation-Induced Progressive Locomotor Deficits in Drosophila



TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson’s disease



Dopamine Signaling Modulates Microglial NLRP3 Inflammasome Activation: Implications for Parkinson’s Disease



MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons.



Pesticides Exposure and Dopaminergic Neurodegeneration



Ncx3-Induced Mitochondrial Dysfunction in Midbrain Leads to Neuroinflammation in Striatum of A53t-α-Synuclein Transgenic Old Mice



Low molecular weight polysialic acid prevents lipopolysaccharide‐induced inflammatory dopaminergic neurodegeneration in humanized SIGLEC11 transgenic mice



Subthalamic beta oscillations correlate with dopaminergic degeneration in experimental parkinsonism



Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors



GSK-3 mediates nuclear translocation of p62/SQSTM1 in MPTP-induced mouse model of Parkinson’s disease



Neuroprotective effect of metformin on dopaminergic neurodegeneration and α-synuclein aggregation in C. elegans model of Parkinson’s disease



Multiple genetic pathways regulating lifespan extension are neuroprotective in a G2019S LRRK2 nematode model of Parkinson’s disease



The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease



Swertiamarin from Enicostemma littorale, counteracts PD associated neurotoxicity via enhancement α-synuclein suppressive genes and SKN-1/NRF-2 activation through MAPK pathway.



Genetically Targeted Clinical Trials in Parkinson’s Disease: Learning from the Successes Made in Oncology



Templated α-Synuclein Inclusion Formation Is Independent of Endogenous Tau



Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor dysfunction and cortical atrophy, independent of protein aggregation



Progresses in both basic research and clinical trials of NAD+ in Parkinson’s disease



Aromatic-Turmerone Analogs Protect Dopaminergic Neurons in Midbrain Slice Cultures through Their Neuroprotective Activities



The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration



Apelin-36 exerts the cytoprotective effect against MPP+-induced cytotoxicity in SH-SY5Y cells through PI3K/Akt/mTOR autophagy pathway.



Rapid eye movement sleep deprivation enhances vulnerability of striatal dopaminergic neurons to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine neurotoxicity in mice


More Dopaminergic Neurodegeneration sentence examples
10.1183/13993003.congress-2019.pa2011

The effects of chronic intermittent hypoxia on dopaminergic neurodegeneration



Astrocytic Oxidative/Nitrosative Stress Contributes to Parkinson’s Disease Pathogenesis: The Dual Role of Reactive Astrocytes



Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro



Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death



(E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) Phenol Ameliorates MPTP-Induced Dopaminergic Neurodegeneration by Inhibiting the STAT3 Pathway



A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease



Lead (Pb) exposure induces dopaminergic neurotoxicity in Caenorhabditis elegans: Involvement of the dopamine transporter



Environmental neurotoxicant‐induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms



Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson’s disease



Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?



Leucine‐rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes



Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in non-human primates



Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson’s disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy



Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism



Fast Intracortical Sensory-Motor Integration: A Window Into the Pathophysiology of Parkinson’s Disease



Dopaminergic Neurodegeneration Induced by Parkinson’s Disease-Linked G2019S LRRK2 is Dependent on Kinase and GTPase Activity



Metabolic response to Parkinson’s disease recapitulated by the haploinsufficient phenotype of diploid yeast cells hemizygous for the adrenodoxin reductase gene


More Dopaminergic Neurodegeneration sentence examples
10.24272/j.issn.2095-8137.2019.053

Stem cell therapy for Parkinson’s disease using non-human primate models



Pyrethroid exposure and neurotoxicity: a mechanistic approach



Involvement of exosomes in dopaminergic neurodegeneration by microglial activation in midbrain slice cultures.



NADPH oxidase regulates paraquat and maneb-induced dopaminergic neurodegeneration through ferroptosis.



Methiopropamine, a methamphetamine analogue, produces neurotoxicity via dopamine receptors.


Learn more from Dopaminergic Neurodegeneration


Dopaminergic Neurodegeneration
Encyclopedia